-
Focus On Byetta
________________________________________________________ Free Byetta Case Evaluation The information you provide to us for this Free Case Evaluation will be treated as strictly confidential. You will get a reply from us no later than the next business day. …
-
There Is Disagreement Over The Three-Year Failure Rate For Sprint Fidelis Lead Wires
Medtronic Says 4.6 Percent Of Leads Failed, While Reports From Some Hospitals Indicate 9.2 Percent Of Sprint Fidelis Wires Failed (Posted by Tom Lamb at DrugInjuryWatch.com) In our December 30, 2009 article, "Sprint Fidelis Lead Wire Failure…
-
Fibromyalgia Drug Savella Should Be Pulled From Market, Says Public Citizen Group
January 2010 Petition Letter To FDA Is Sent One Year After The Medication Was Approved For Sale In U.S. (Posted by Tom Lamb at DrugInjuryWatch.com) On January 21, 2010 the Health Research Group arm…
-
Should Meridia Remain On Market? FDA Says “Yes” (For Now At Least), European Drug Regulators Say “No”
Difference Of Opinion Suggests There Could Be A Possible Meridia Recall In U.S. Before The FDA Holds Its Public Advisory Meeting In September 2010(Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: Abbott Pulls Meridia in U.S. Amid…
-
National Alert Network For Serious Medication Errors: New Drug-Safety Project From ISMP And ASHP
Will Send Email Alerts To Healthcare Providers When Dangerous Or Life-Threatening Prescription Drug Errors Are Reported To ISMP (Posted by Tom Lamb at DrugInjuryWatch.com) A January 19, 2010 article, "Catching Deadly Drug Mistakes", by…